Aura Biosciences, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -23.1% | -23.1% | -22.0% |
| FY2022 | -30.0% | -30.0% | -26.2% |
| FY2023 | -33.8% | -33.8% | -30.0% |
| FY2024 | -57.2% | -57.2% | -47.6% |
| FY2025 | -77.6% | -77.6% | -62.7% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -23.1% | -23.1% | -22.0% |
| FY2022 | -30.0% | -30.0% | -26.2% |
| FY2023 | -33.8% | -33.8% | -30.0% |
| FY2024 | -57.2% | -57.2% | -47.6% |
| FY2025 | -77.6% | -77.6% | -62.7% |